Sonoma Pharmaceuticals (SNOA) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.26
-0.87
-0.47
-0.07

Details

Expected EPS
-1
Actual EPS
-1.26494
Surprise EPS
-0.26
Surprise Percent
+26.49%

Description

Sonoma Pharmaceuticals (SNOA) has reported earnings of -1.26494 per share for Q3 2024.

0 Comments

Share your thoughts